OMNICEF 300 mg Logo (Cefdinir 300 mg)
Pill imprint OMNICEF 300 mg Logo has been identified as Cefdinir 300 mg.
Cefdinir is used in the treatment of sinusitis; skin and structure infection; strep throat; bronchitis; otitis media (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Cefdinir 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for OMNICEF 300 mg Logo
OMNICEF 300 mg
- 300 mg
- Purple / Blue
- Prescription only
- Drug Class:
- Third generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Dava Pharmaceuticals Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|55289-0081||PDRX Pharmaceuticals Inc (repackager)|
|35356-0038||Lake Erie Medical and Surgical Supply (repackager)|
|55887-0187||Diversified Healthcare Services Inc (repackager)|
|54868-5767||Physicians Total Care Inc (repackager)|
|18837-0244||Innoviant Pharmacy Inc (repackager)|
|55289-0831||PDRX Pharmaceuticals Inc (repackager)|
|54868-4366||Physicians Total Care Inc (repackager)|
|54569-5214||A S Medication Solutions LLC (repackager)|
|66336-0104||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about cefdinir
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.